Key statistics dashboard for Sight Sciences, Inc. (SGHT). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients.
Stock Data
| Price | $8.14 |
| Market Cap | $443M |
| Enterprise Value | $405.1M |
| Beta | 2.49 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -14.58 |
| Price / Book | 8.39 |
| P/S | 5.31 |
| EV/EBITDA | -15.74 |
| EV/Sales | 4.86 |
| EV/FCF | -17.36 |
| P/FCF | -18.98 |
| Earnings Yield | -6.71% |
| FCF Yield | -5.27% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 87.96% |
| EBIT Margin | -31.37% |
| EBITDA Margin | -30.88% |
| Operating Margin | -33.43% |
| Net Margin | -35.69% |
| Return on Equity | -50.64% |
| Return on Assets | -28.37% |
| Return on Invested Capital | -29.34% |
| Return on Capital Employed | -33.04% |
Financial Health
| Current Ratio | 4.95 |
| Quick Ratio | 4.67 |
| Cash Ratio | 3.89 |
| Debt / Equity | 0.79 |
| Debt / Assets | 40.02% |
| Net Debt / EBITDA | 1.47 |
| Interest Coverage | -10.65 |
Per-Share Data
| Revenue per share | 1.53 |
| Book Value per share | 0.97 |
| Cash per share | 1.46 |
| FCF per share | -0.43 |
| Tangible Book Value per share | 0.97 |
| Dividend per share | 0.00 |
Related companies: CERS · CVRX · LFCR · MASS · OMI · PRQR · QTRX
Explore sector: Healthcare · Medical - Devices
More sections of SGHT: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks